The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
10450960 |
3 |
Isolation and structure of SCH 351633: a novel hepatitis C virus (HCV) NS3 protease inhibitor from the fungus Penicillium griseofulvum. |
Schering-Plough Research Institute |
17113777 |
1 |
Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors. |
Uppsala University |
16078825 |
8 |
Design and synthesis of depeptidized macrocyclic inhibitors of hepatitis C NS3-4A protease using structure-based drug design. |
Schering-Plough Research Institute |
15633995 |
66 |
Control of hepatitis C: a medicinal chemistry perspective. |
University of Wollongong |
15546725 |
3 |
Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease. |
Peking University |
11206459 |
29 |
Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain. |
Uppsala University |
11055336 |
2 |
NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain. |
Boehringer Ingelheim Pharmaceuticals |
11055335 |
27 |
Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors. |
Boehringer Ingelheim Pharmaceuticals |
9873421 |
30 |
Peptide-based inhibitors of the hepatitis C virus serine protease. |
Boehringer Ingelheim (Canada) |
16730985 |
13 |
P2-P4 macrocyclic inhibitors of hepatitis C virus NS3-4A serine protease. |
Schering-Plough Research Institute |
16722622 |
24 |
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site. |
Wyeth Research |
16274990 |
21 |
Design and synthesis of 3,4-dihydro-1H-[1]-benzothieno[2,3-c]pyran and 3,4-dihydro-1H-pyrano[3,4-b]benzofuran derivatives as non-nucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase. |
Wyeth Research |
16190750 |
7 |
Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease. |
Schering-Plough Research Institute |
16112859 |
6 |
Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease. |
Schering-Plough Research Institute |
15982872 |
24 |
Investigation of glycine alpha-ketoamide HCV NS3 protease inhibitors: effect of carboxylic acid isosteres. |
Pharmaceutical Research Institute |
15588076 |
6 |
The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease. |
Mrl Rome |
15341970 |
59 |
P4 and P1' optimization of bicycloproline P2 bearing tetrapeptidyl alpha-ketoamides as HCV protease inhibitors. |
Eli Lilly |
15261297 |
18 |
P4 cap modified tetrapeptidyl alpha-ketoamides as potent HCV NS3 protease inhibitors. |
Eli Lilly |
15115392 |
52 |
Non-peptidic small-molecule inhibitors of the single-chain hepatitis C virus NS3 protease/NS4A cofactor complex discovered by structure-based NMR screening. |
Schering-Plough Research Institute |
15006379 |
44 |
Inhibitors of hepatitis C virus NS3.4A protease 2. Warhead SAR and optimization. |
Vertex Pharmaceuticals |
14695826 |
13 |
NMR structural characterization of peptide inhibitors bound to the Hepatitis C virus NS3 protease: design of a new P2 substituent. |
Boehringer Ingelheim (Canada) |
14611859 |
3 |
Two antiviral compounds from the plant Stylogne cauliflora as inhibitors of HCV NS3 protease. |
Schering-Plough Research Institute |
12873506 |
8 |
Novel, potent phenethylamide inhibitors of the hepatitis C virus (HCV) NS3 protease: probing the role of P2 aryloxyprolines with hybrid structures. |
Mrl Rome |
12643933 |
27 |
Design and synthesis of potent, non-peptide inhibitors of HCV NS3 protease. |
Bristol-Myers Squibb |
12617891 |
37 |
Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitors. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
12540231 |
39 |
Phenethyl amides as novel noncovalent inhibitors of hepatitis C virus NS3/4A protease: discovery, initial SAR, and molecular modeling. |
Mrl Rome |
12372533 |
69 |
P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
11909704 |
43 |
Azapeptides as inhibitors of the hepatitis C virus NS3 serine protease. |
Schering-Plough Research Institute |
11844690 |
8 |
Solution and solid-phase synthesis of potent inhibitors of hepatitis C virus NS3 proteinase. |
Roche Discovery Welwyn |
11527730 |
27 |
Structure-activity relationship studies of a bisbenzimidazole-based, Zn(2+)-dependent inhibitor of HCV NS3 serine protease. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
11206478 |
18 |
Arylalkylidene rhodanine with bulky and hydrophobic functional group as selective HCV NS3 protease inhibitor. |
Institute of Molecular and Cell Biology |
10782670 |
11 |
Alpha-ketoamides, alpha-ketoesters and alpha-diketones as HCV NS3 protease inhibitors. |
Dupont Pharmaceuticals |
9171866 |
12 |
Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy. |
Merck Research Laboratories |
29477077 |
17 |
Pan-NS3 protease inhibitors of hepatitis C virus based on an R |
Uppsala University |
29162454 |
43 |
The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. |
Bristol-Myers Squibb |